{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T18:31:19Z","timestamp":1784313079208,"version":"3.55.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T00:00:00Z","timestamp":1660521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T00:00:00Z","timestamp":1660521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PGC463531"],"award-info":[{"award-number":["PGC463531"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003400","name":"Ontario Ministry of Research, Innovation and Science","doi-asserted-by":"publisher","award":["RE9"],"award-info":[{"award-number":["RE9"]}],"id":[{"id":"10.13039\/501100003400","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Chem Biol"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1038\/s41589-022-01109-0","type":"journal-article","created":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T16:02:46Z","timestamp":1660579366000},"page":"1370-1379","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Chemical genomics with pyrvinium identifies C1orf115 as a regulator of drug efflux"],"prefix":"10.1038","volume":"18","author":[{"given":"Sanna N.","family":"Masud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megha","family":"Chandrashekhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6443-9870","authenticated-orcid":false,"given":"Michael","family":"Aregger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7334-1154","authenticated-orcid":false,"given":"Guihong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Mero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Pirman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Zaslaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0136-4685","authenticated-orcid":false,"given":"Gromoslaw A.","family":"Smolen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Yuan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassandra J.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3542-6760","authenticated-orcid":false,"given":"Charles","family":"Boone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6090-4437","authenticated-orcid":false,"given":"Anne-Claude","family":"Gingras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7787-3414","authenticated-orcid":false,"given":"J. Rafael","family":"Montenegro-Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5663-8586","authenticated-orcid":false,"given":"Jason","family":"Moffat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,15]]},"reference":[{"key":"1109_CR1","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cell.2019.01.033","volume":"177","author":"M Costanzo","year":"2019","unstructured":"Costanzo, M. et al. Global genetic networks and the genotype-to-phenotype relationship. Cell 177, 85\u2013100 (2019).","journal-title":"Cell"},{"key":"1109_CR2","doi-asserted-by":"crossref","first-page":"349","DOI":"10.4269\/ajtmh.1959.8.349","volume":"8","author":"JW Beck","year":"1959","unstructured":"Beck, J. W., Saavedra, D., Antell, G. J. & Tejeiro, B. The treatment of pinworm infections in humans (enterobiasis) with pyrvinium chloride and pyrvinium pamoate. Am. J. Trop. Med Hyg. 8, 349\u2013352 (1959).","journal-title":"Am. J. Trop. Med Hyg."},{"key":"1109_CR3","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.canlet.2011.12.034","volume":"319","author":"Y Harada","year":"2012","unstructured":"Harada, Y., Ishii, I., Hatake, K. & Kasahara, T. Pyrvinium pamoate inhibits proliferation of myeloma\/erythroleukemia cells by suppressing mitochondrial respiratory complex I and STAT3. Cancer Lett. 319, 83\u201388 (2012).","journal-title":"Cancer Lett."},{"key":"1109_CR4","doi-asserted-by":"crossref","first-page":"e101969","DOI":"10.1371\/journal.pone.0101969","volume":"9","author":"B Li","year":"2014","unstructured":"Li, B. et al. Repurposing the FDA-approved pinworm drug pyrvinium as a novel chemotherapeutic agent for intestinal polyposis. PLoS ONE 9, e101969 (2014).","journal-title":"PLoS ONE"},{"key":"1109_CR5","doi-asserted-by":"crossref","first-page":"5324","DOI":"10.1158\/1078-0432.CCR-14-3147","volume":"21","author":"C Venugopal","year":"2015","unstructured":"Venugopal, C. et al. Pyrvinium targets CD133 in human glioblastoma brain tumor-initiating cells. Clin. Cancer Res. 21, 5324\u20135337 (2015).","journal-title":"Clin. Cancer Res."},{"key":"1109_CR6","doi-asserted-by":"crossref","first-page":"33769","DOI":"10.18632\/oncotarget.5615","volume":"6","author":"W Xiang","year":"2015","unstructured":"Xiang, W. et al. Pyrvinium selectively targets blast phase-chronic myeloid leukemia through inhibition of mitochondrial respiration. Oncotarget 6, 33769\u201333780 (2015).","journal-title":"Oncotarget"},{"key":"1109_CR7","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/nchembio.453","volume":"6","author":"CA Thorne","year":"2010","unstructured":"Thorne, C. A. et al. Small-molecule inhibition of Wnt signaling through activation of casein kinase 1\u03b1. Nat. Chem. Biol. 6, 829\u2013836 (2010).","journal-title":"Nat. Chem. Biol."},{"key":"1109_CR8","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/nm.4219","volume":"23","author":"Z Steinhart","year":"2017","unstructured":"Steinhart, Z. et al. Genome-wide CRISPR screens reveal a Wnt-FZD5 signaling circuit as a druggable vulnerability of RNF43-mutant pancreatic tumors. Nat. Med. 23, 60\u201368 (2017).","journal-title":"Nat. Med."},{"key":"1109_CR9","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.amjms.2017.11.017","volume":"355","author":"L Cui","year":"2018","unstructured":"Cui, L., Zhao, J. & Liu, J. Pyrvinium sensitizes clear cell renal cell carcinoma response to chemotherapy via casein kinase 1\u03b1-dependent inhibition of Wnt\/\u03b2-catenin. Am. J. Med Sci. 355, 274\u2013280 (2018).","journal-title":"Am. J. Med Sci."},{"key":"1109_CR10","doi-asserted-by":"crossref","first-page":"266","DOI":"10.12659\/MSM.901667","volume":"23","author":"C Zhang","year":"2017","unstructured":"Zhang, C., Zhang, Z., Zhang, S., Wang, W. & Hu, P. Targeting of Wnt\/\u03b2-catenin by anthelmintic drug pyrvinium enhances sensitivity of ovarian cancer cells to chemotherapy. Med Sci. Monit. 23, 266\u2013275 (2017).","journal-title":"Med Sci. Monit."},{"key":"1109_CR11","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/abbs\/gmx089","volume":"49","author":"L Zheng","year":"2017","unstructured":"Zheng, L., Liu, Y. & Pan, J. Inhibitory effect of pyrvinium pamoate on uveal melanoma cells involves blocking of Wnt\/\u03b2-catenin pathway. Acta Biochim. Biophys. Sin. 49, 890\u2013898 (2017).","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"1109_CR12","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.cell.2015.11.015","volume":"163","author":"T Hart","year":"2015","unstructured":"Hart, T. et al. High-resolution CRISPR screens reveal fitness genes and genotype-specific cancer liabilities. Cell 163, 1515\u20131526 (2015).","journal-title":"Cell"},{"key":"1109_CR13","volume":"21","author":"MT Lau","year":"2020","unstructured":"Lau, M. T. et al. Systematic functional identification of cancer multi-drug resistance genes. Genome Biol. 21, 27 (2020).","journal-title":"Genome Biol."},{"key":"1109_CR14","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1021\/acsomega.8b03205","volume":"4","author":"SK Pal","year":"2019","unstructured":"Pal, S. K. et al. Mechanistic investigation of the androgen receptor DNA-binding domain inhibitor pyrvinium. ACS Omega 4, 2472\u20132481 (2019).","journal-title":"ACS Omega"},{"key":"1109_CR15","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nchembio.137","volume":"5","author":"B Chen","year":"2009","unstructured":"Chen, B. et al. Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer. Nat. Chem. Biol. 5, 100\u2013107 (2009).","journal-title":"Nat. Chem. Biol."},{"key":"1109_CR16","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.3727\/096504017X14992942781895","volume":"25","author":"D Polosukhina","year":"2017","unstructured":"Polosukhina, D. et al. Pharmacologic Inhibition of \u03b2-catenin with pyrvinium inhibits murine and human models of Wilms tumor. Oncol. Res 25, 1653\u20131664 (2017).","journal-title":"Oncol. Res"},{"key":"1109_CR17","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature13110","volume":"508","author":"K Birsoy","year":"2014","unstructured":"Birsoy, K. et al. Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides. Nature 508, 108\u2013112 (2014).","journal-title":"Nature"},{"key":"1109_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.33549\/physiolres.932600","volume":"63","author":"Z Drahota","year":"2014","unstructured":"Drahota, Z. et al. Biguanides inhibit complex I, II and IV of rat liver mitochondria and modify their functional properties. Physiol. Res 63, 1\u201311 (2014).","journal-title":"Physiol. Res"},{"key":"1109_CR19","doi-asserted-by":"crossref","first-page":"e202100674","DOI":"10.1002\/cmdc.202100674","volume":"17","author":"J Fu","year":"2022","unstructured":"Fu, J. et al. Biguanide MC001, a dual inhibitor of OXPHOS and glycolysis, shows enhanced anti-tumor activity without increasing lactate production. ChemMedChem 17, e202100674 (2022).","journal-title":"ChemMedChem"},{"key":"1109_CR20","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/toxsci\/kfs330","volume":"132","author":"Y Shitara","year":"2013","unstructured":"Shitara, Y. et al. Role of organic cation\/carnitine transporter 1 in uptake of phenformin and inhibitory effect on complex I respiration in mitochondria. Toxicol. Sci. 132, 32\u201342 (2013).","journal-title":"Toxicol. Sci."},{"key":"1109_CR21","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.cmet.2016.08.017","volume":"24","author":"JD Arroyo","year":"2016","unstructured":"Arroyo, J. D. et al. A genome-wide CRISPR death screen identifies genes essential for oxidative phosphorylation. Cell Metab. 24, 875\u2013885 (2016).","journal-title":"Cell Metab."},{"key":"1109_CR22","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/2049-3002-2-12","volume":"2","author":"S Andrzejewski","year":"2014","unstructured":"Andrzejewski, S., Gravel, S. P., Pollak, M. & St-Pierre, J. Metformin directly acts on mitochondria to alter cellular bioenergetics. Cancer Metab. 2, 12 (2014).","journal-title":"Cancer Metab."},{"key":"1109_CR23","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1534\/g3.117.041277","volume":"7","author":"T Hart","year":"2017","unstructured":"Hart, T. et al. Evaluation and design of genome-wide CRISPR\/SpCas9 knockout screens. G3 (Bethesda) 7, 2719\u20132727 (2017).","journal-title":"G3 (Bethesda)"},{"key":"1109_CR24","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.cell.2017.01.013","volume":"168","author":"T Wang","year":"2017","unstructured":"Wang, T. et al. Gene essentiality profiling reveals gene networks and synthetic lethal interactions with oncogenic Ras. Cell 168, 890\u2013903 (2017).","journal-title":"Cell"},{"key":"1109_CR25","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/FPC.0b013e3283385a1c","volume":"21","author":"LM Hodges","year":"2011","unstructured":"Hodges, L. M. et al. Very important pharmacogene summary: ABCB1 (MDR1, P-glycoprotein). Pharmacogenet. Genomics 21, 152\u2013161 (2011).","journal-title":"Pharmacogenet. Genomics"},{"key":"1109_CR26","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.cell.2019.10.032","volume":"179","author":"TL To","year":"2019","unstructured":"To, T. L. et al. A compendium of genetic modifiers of mitochondrial dysfunction reveals intra-organelle buffering. Cell 179, 1222\u20131238 e17 (2019).","journal-title":"Cell"},{"key":"1109_CR27","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.cell.2015.07.016","volume":"162","author":"K Birsoy","year":"2015","unstructured":"Birsoy, K. et al. An essential role of the mitochondrial electron transport chain in cell proliferation is to enable aspartate synthesis. Cell 162, 540\u2013551 (2015).","journal-title":"Cell"},{"key":"1109_CR28","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/s41556-018-0118-z","volume":"20","author":"J Garcia-Bermudez","year":"2018","unstructured":"Garcia-Bermudez, J. et al. Aspartate is a limiting metabolite for cancer cell proliferation under hypoxia and in tumours. Nat. Cell Biol. 20, 775\u2013781 (2018).","journal-title":"Nat. Cell Biol."},{"key":"1109_CR29","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1038\/s41556-018-0184-2","volume":"20","author":"J Garcia-Bermudez","year":"2018","unstructured":"Garcia-Bermudez, J. et al. Publisher correction: aspartate is a limiting metabolite for cancer cell proliferation under hypoxia and in tumours. Nat. Cell Biol. 20, 1228 (2018).","journal-title":"Nat. Cell Biol."},{"key":"1109_CR30","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.cell.2015.07.017","volume":"162","author":"LB Sullivan","year":"2015","unstructured":"Sullivan, L. B. et al. Supporting aspartate biosynthesis is an essential function of respiration in proliferating cells. Cell 162, 552\u2013563 (2015).","journal-title":"Cell"},{"key":"1109_CR31","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/s41556-018-0125-0","volume":"20","author":"LB Sullivan","year":"2018","unstructured":"Sullivan, L. B. et al. Aspartate is an endogenous metabolic limitation for tumour growth. Nat. Cell Biol. 20, 782\u2013788 (2018).","journal-title":"Nat. Cell Biol."},{"key":"1109_CR32","doi-asserted-by":"crossref","first-page":"E430","DOI":"10.1073\/pnas.1514375113","volume":"113","author":"Y Mugabo","year":"2016","unstructured":"Mugabo, Y. et al. Identification of a mammalian glycerol-3-phosphate phosphatase: role in metabolism and signaling in pancreatic \u03b2-cells and hepatocytes. Proc. Natl Acad. Sci. USA 113, E430\u2013E439 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1109_CR33","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1074\/jbc.M113.503359","volume":"289","author":"A Seifried","year":"2014","unstructured":"Seifried, A. et al. Evolutionary and structural analyses of mammalian haloacid dehalogenase-type phosphatases AUM and chronophin provide insight into the basis of their different substrate specificities. J. Biol. Chem. 289, 3416\u20133431 (2014).","journal-title":"J. Biol. Chem."},{"key":"1109_CR34","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.biochi.2017.08.001","volume":"143","author":"E Possik","year":"2017","unstructured":"Possik, E., Madiraju, S. R. M. & Prentki, M. Glycerol-3-phosphate phosphatase\/PGP: role in intermediary metabolism and target for cardiometabolic diseases. Biochimie 143, 18\u201328 (2017).","journal-title":"Biochimie"},{"key":"1109_CR35","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.mce.2011.11.004","volume":"353","author":"M Prentki","year":"2012","unstructured":"Prentki, M. & Madiraju, S. R. Glycerolipid\/free fatty acid cycle and islet \u03b2-cell function in health, obesity and diabetes. Mol. Cell. Endocrinol. 353, 88\u2013100 (2012).","journal-title":"Mol. Cell. Endocrinol."},{"key":"1109_CR36","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/nchembio.2104","volume":"12","author":"F Collard","year":"2016","unstructured":"Collard, F. et al. A conserved phosphatase destroys toxic glycolytic side products in mammals and yeast. Nat. Chem. Biol. 12, 601\u2013607 (2016).","journal-title":"Nat. Chem. Biol."},{"key":"1109_CR37","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cell.2006.05.036","volume":"126","author":"K Bensaad","year":"2006","unstructured":"Bensaad, K. et al. TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 126, 107\u2013120 (2006).","journal-title":"Cell"},{"key":"1109_CR38","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0003-9861(84)90043-2","volume":"228","author":"DE Ash","year":"1984","unstructured":"Ash, D. E., Goodhart, P. J. & Reed, G. H. ATP-dependent phosphorylation of \u03b1-substituted carboxylic acids catalyzed by pyruvate kinase. Arch. Biochem. Biophys. 228, 31\u201340 (1984).","journal-title":"Arch. Biochem. Biophys."},{"key":"1109_CR39","doi-asserted-by":"crossref","first-page":"e1600200","DOI":"10.1126\/sciadv.1600200","volume":"2","author":"RJ DeBerardinis","year":"2016","unstructured":"DeBerardinis, R. J. & Chandel, N. S. Fundamentals of cancer metabolism. Sci. Adv. 2, e1600200 (2016).","journal-title":"Sci. Adv."},{"key":"1109_CR40","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0005-2728(99)00051-1","volume":"1412","author":"BB Seo","year":"1999","unstructured":"Seo, B. B., Matsuno-Yagi, A. & Yagi, T. Modulation of oxidative phosphorylation of human kidney 293 cells by transfection with the internal rotenone-insensitive NADH-quinone oxidoreductase (NDI1) gene of Saccharomyces cerevisiae. Biochim. Biophys. Acta 1412, 56\u201365 (1999).","journal-title":"Biochim. Biophys. Acta"},{"key":"1109_CR41","doi-asserted-by":"crossref","first-page":"e02242","DOI":"10.7554\/eLife.02242","volume":"3","author":"WW Wheaton","year":"2014","unstructured":"Wheaton, W. W. et al. Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis. Elife 3, e02242 (2014).","journal-title":"Elife"},{"key":"1109_CR42","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami, E. et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2, 401\u2013404 (2012).","journal-title":"Cancer Discov."},{"key":"1109_CR43","first-page":"pl1","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao, J. et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal 6, pl1 (2013).","journal-title":"Sci. Signal"},{"key":"1109_CR44","volume":"8","author":"A Nagy","year":"2018","unstructured":"Nagy, A., Lanczky, A., Menyhart, O. & Gyorffy, B. Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets. Sci. Rep. 8, 9227 (2018).","journal-title":"Sci. Rep."},{"key":"1109_CR45","volume":"8","author":"A Nagy","year":"2018","unstructured":"Nagy, A., Lanczky, A., Menyhart, O. & Gyorffy, B. Author correction: validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets. Sci. Rep. 8, 11515 (2018).","journal-title":"Sci. Rep."},{"key":"1109_CR46","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1042\/BCJ20180435","volume":"476","author":"I Gerin","year":"2019","unstructured":"Gerin, I. et al. Phosphoglycolate has profound metabolic effects but most likely no role in a metabolic DNA response in cancer cell lines. Biochem. J. 476, 629\u2013643 (2019).","journal-title":"Biochem. J."},{"key":"1109_CR47","doi-asserted-by":"crossref","DOI":"10.1186\/s13073-019-0665-3","volume":"11","author":"M Colic","year":"2019","unstructured":"Colic, M. et al. Identifying chemogenetic interactions from CRISPR screens with drugZ. Genome Med 11, 52 (2019).","journal-title":"Genome Med"},{"key":"1109_CR48","doi-asserted-by":"crossref","first-page":"733","DOI":"10.15252\/msb.20145216","volume":"10","author":"T Hart","year":"2014","unstructured":"Hart, T., Brown, K. R., Sircoulomb, F., Rottapel, R. & Moffat, J. Measuring error rates in genomic perturbation screens: gold standards for human functional genomics. Mol. Syst. Biol. 10, 733 (2014).","journal-title":"Mol. Syst. Biol."},{"key":"1109_CR49","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12859-016-1015-8","volume":"17","author":"T Hart","year":"2016","unstructured":"Hart, T. & Moffat, J. BAGEL: a computational framework for identifying essential genes from pooled library screens. BMC Bioinf. 17, 164 (2016).","journal-title":"BMC Bioinf."},{"key":"1109_CR50","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nmeth.3047","volume":"11","author":"NE Sanjana","year":"2014","unstructured":"Sanjana, N. E., Shalem, O. & Zhang, F. Improved vectors and genome-wide libraries for CRISPR screening. Nat. Methods 11, 783\u2013784 (2014).","journal-title":"Nat. Methods"},{"key":"1109_CR51","doi-asserted-by":"crossref","first-page":"6332","DOI":"10.1093\/nar\/gkt322","volume":"41","author":"LC Wan","year":"2013","unstructured":"Wan, L. C. et al. Reconstitution and characterization of eukaryotic N6-threonylcarbamoylation of tRNA using a minimal enzyme system. Nucleic Acids Res. 41, 6332\u20136346 (2013).","journal-title":"Nucleic Acids Res."},{"key":"1109_CR52","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/978-1-4939-6747-6_10","volume":"1550","author":"GG Hesketh","year":"2017","unstructured":"Hesketh, G. G., Youn, J. Y., Samavarchi-Tehrani, P., Raught, B. & Gingras, A. C. Parallel exploration of interaction space by BioID and affinity purification coupled to mass spectrometry. Methods Mol. Biol. 1550, 115\u2013136 (2017).","journal-title":"Methods Mol. Biol."},{"key":"1109_CR53","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/nbt.4201","volume":"36","author":"TC Branon","year":"2018","unstructured":"Branon, T. C. et al. Efficient proximity labeling in living cells and organisms with TurboID. Nat. Biotechnol. 36, 880\u2013887 (2018).","journal-title":"Nat. Biotechnol."},{"key":"1109_CR54","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s42255-020-0211-z","volume":"2","author":"M Aregger","year":"2020","unstructured":"Aregger, M. et al. Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism. Nat. Metab. 2, 499\u2013513 (2020).","journal-title":"Nat. Metab."},{"key":"1109_CR55","unstructured":"Burke, D., Dawson, D. & Stearns, T. Methods in Yeast Genetics: a Cold Spring Harbor Laboratory Course Manual (Cold Spring Harbor Laboratory Press, 2000)."},{"key":"1109_CR56","doi-asserted-by":"crossref","first-page":"pdb.prot085100","DOI":"10.1101\/pdb.prot085100","volume":"2015","author":"J van Leeuwen","year":"2015","unstructured":"van Leeuwen, J., Andrews, B., Boone, C. & Tan, G. Rapid and efficient plasmid construction by homologous recombination in yeast. Cold Spring Harb. Protoc. 2015, pdb.prot085100 (2015).","journal-title":"Cold Spring Harb. Protoc."}],"updated-by":[{"DOI":"10.1038\/s41589-022-01146-9","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T00:00:00Z","timestamp":1661299200000}}],"container-title":["Nature Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41589-022-01109-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41589-022-01109-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41589-022-01109-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,25]],"date-time":"2023-11-25T20:13:10Z","timestamp":1700943190000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41589-022-01109-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,15]]},"references-count":56,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1109"],"URL":"https:\/\/doi.org\/10.1038\/s41589-022-01109-0","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41589-022-01146-9","asserted-by":"object"}]},"ISSN":["1552-4450","1552-4469"],"issn-type":[{"value":"1552-4450","type":"print"},{"value":"1552-4469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,15]]},"assertion":[{"value":"7 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41589-022-01146-9","URL":"https:\/\/doi.org\/10.1038\/s41589-022-01146-9","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.M. is an advisor and shareholder of Century Therapeutics and Aelian Biotechnology.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}